238 related articles for article (PubMed ID: 15265021)
1. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis.
Smith KC; Bateman AC; Fussell HM; Howell WM
Eur J Immunogenet; 2004 Aug; 31(4):167-73. PubMed ID: 15265021
[TBL] [Abstract][Full Text] [Related]
2. Influence of cytokine gene polymorphisms on the development of prostate cancer.
McCarron SL; Edwards S; Evans PR; Gibbs R; Dearnaley DP; Dowe A; Southgate C; Easton DF; Eeles RA; Howell WM
Cancer Res; 2002 Jun; 62(12):3369-72. PubMed ID: 12067976
[TBL] [Abstract][Full Text] [Related]
3. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
Farjadfar A; Mojtahedi Z; Ghayumi MA; Erfani N; Haghshenas MR; Ghaderi A
Acta Oncol; 2009; 48(7):971-6. PubMed ID: 19642044
[TBL] [Abstract][Full Text] [Related]
5. An association study of inflammatory cytokine gene polymorphisms in Fabry disease.
Safyan R; Whybra C; Beck M; Elstein D; Altarescu G
Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161
[TBL] [Abstract][Full Text] [Related]
6. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.
Snoussi K; Strosberg AD; Bouaouina N; Ben Ahmed S; Chouchane L
Eur Cytokine Netw; 2005 Dec; 16(4):253-60. PubMed ID: 16464738
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
[TBL] [Abstract][Full Text] [Related]
9. Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity.
Azmy IA; Balasubramanian SP; Wilson AG; Stephenson TJ; Cox A; Brown NJ; Reed MW
Breast Cancer Res; 2004; 6(4):R395-400. PubMed ID: 15217507
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.
Försti A; Jin Q; Altieri A; Johansson R; Wagner K; Enquist K; Grzybowska E; Pamula J; Pekala W; Hallmans G; Lenner P; Hemminki K
Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673
[TBL] [Abstract][Full Text] [Related]
11. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
12. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
[TBL] [Abstract][Full Text] [Related]
14. Cytokine gene polymorphisms and breast cancer susceptibility.
Scola L; Vaglica M; Crivello A; Palmeri L; Forte GI; Macaluso MC; Giacalone A; Di Noto L; Bongiovanni A; Raimondi C; Accardo A; Verna R; Candore G; Caruso C; Lio D; Palmeri S
Ann N Y Acad Sci; 2006 Nov; 1089():104-9. PubMed ID: 17261759
[TBL] [Abstract][Full Text] [Related]
15. Relation between cytokine promoter gene polymorphism and toxicity of 5-fluorouracil plus cisplatin chemotherapy.
Sakamoto K; Oka M; Yoshino S; Hazama S; Abe T; Okayama N; Hinoda Y
Oncol Rep; 2006 Aug; 16(2):381-7. PubMed ID: 16820919
[TBL] [Abstract][Full Text] [Related]
16. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
Lei H; Hemminki K; Altieri A; Johansson R; Enquist K; Hallmans G; Lenner P; Försti A
Breast Cancer Res Treat; 2007 May; 103(1):61-9. PubMed ID: 17033924
[TBL] [Abstract][Full Text] [Related]
17. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.
Howell WM; Turner SJ; Bateman AC; Theaker JM
Genes Immun; 2001 Feb; 2(1):25-31. PubMed ID: 11294564
[TBL] [Abstract][Full Text] [Related]
18. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
19. Cytokine genotypes in acute pancreatitis: association with etiology, severity, and cytokine levels in blood.
de-Madaria E; Martínez J; Sempere L; Lozano B; Sánchez-Payá J; Uceda F; Pérez-Mateo M
Pancreas; 2008 Oct; 37(3):295-301. PubMed ID: 18815552
[TBL] [Abstract][Full Text] [Related]
20. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity.
Balding J; Kane D; Livingstone W; Mynett-Johnson L; Bresnihan B; Smith O; FitzGerald O
Arthritis Rheum; 2003 May; 48(5):1408-13. PubMed ID: 12746914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
